These data demonstrated that LTB4/BLT1 signaling is critical for controlling MRSA skin infections in vivo and further showed its therapeutic potential for controlling MRSA skin infections in the absence of LTB4. The gene discussed is LTB4R; the disease is methicillin-resistant staphylococcus aureus infectious disease.